Structures by: Liu S. G.
Total: 20
C26H16N4O4
C26H16N4O4
New J. Chem. (2017)
a=5.588(3)Å b=7.545(4)Å c=11.984(6)Å
α=77.113(11)° β=88.392(13)° γ=87.412(12)°
C26H16N4O6
C26H16N4O6
New J. Chem. (2017)
a=27.561(3)Å b=4.6812(2)Å c=21.646(4)Å
α=90.00° β=128.914(17)° γ=90.00°
C26H16N4O4
C26H16N4O4
New J. Chem. (2017)
a=22.760(8)Å b=4.6927(12)Å c=21.335(8)Å
α=90.00° β=115.96(5)° γ=90.00°
C46.6H28Cl2CoN8O10.6
C46.6H28Cl2CoN8O10.6
CrystEngComm (2018) 20, 27 3891
a=10.536(2)Å b=10.7340(14)Å c=10.9542(19)Å
α=88.266(12)° β=64.71(2)° γ=82.158(14)°
C33.8H21CoN8O12.8
C33.8H21CoN8O12.8
CrystEngComm (2018) 20, 27 3891
a=17.0537(5)Å b=13.2958(4)Å c=15.2889(4)Å
α=90.00° β=103.065(3)° γ=90.00°
C99H69Cl15Co2N20O18S4
C99H69Cl15Co2N20O18S4
CrystEngComm (2018) 20, 27 3891
a=16.4090(8)Å b=27.965(2)Å c=12.6898(8)Å
α=90° β=106.692(6)° γ=90°
[N,N'-Bis[2-(methylsulfanyl)phenyl]pyridine-2,6-dicarboxamidato(2-)]nickel(II)
C21H17N3NiO2S2
Acta Crystallographica Section E (2004) 60, 8 m1153-m1155
a=11.430(2)Å b=11.406(2)Å c=15.087(3)Å
α=90.00° β=96.765(4)° γ=90.00°
N,N'-Bis[2-(methylsulfanyl)phenyl]pyridine-2,6-dicarboxamide
C21H19N3O2S2
Acta Crystallographica Section E (2004) 60, 9 o1527-o1529
a=8.8370(18)Å b=15.488(3)Å c=15.155(3)Å
α=90.00° β=105.87(3)° γ=90.00°
2-(2-pyridyl)benzo[1,2-d-4,5-d']diimidazole
C13H9N5
Acta Crystallographica Section E (2004) 60, 1 o77-o78
a=10.3841(13)Å b=10.0409(13)Å c=21.911(3)Å
α=90.00° β=90.00° γ=90.00°
2C6H16N,C20H14O12Si22
2C6H16N,C20H14O12Si22
Acta Crystallographica Section C (1996) 52, 12 3179-3181
a=9.625(3)Å b=20.989(3)Å c=17.653(2)Å
α=90° β=90° γ=90°
1-(Benzimidazol-2-ylmethyl)-1H-benzotriazole hemihydrate
C14H11N5,0.5H2O
Acta Crystallographica Section E (2007) 63, 4 o1827-o1828
a=12.973(3)Å b=7.7999(14)Å c=13.569(2)Å
α=90.00° β=96.300(4)° γ=90.00°
N,N'-Bis(4-methyl-2-benzothiazolyl)pyridine-2,6-dicarboxamide N,N-dimethylformamide solvate
C23H17N5O2S2,C3H7NO
Acta Crystallographica Section E (2007) 63, 4 o1704-o1705
a=17.346(4)Å b=7.6140(15)Å c=19.734(4)Å
α=90.00° β=98.22(3)° γ=90.00°
Bis(tetraethylammonium) bis[N,N'-bis(4-methylbenzothiazol-2-yl)pyridine- 2,6-dicarboxamidato(2-)]nickel(II) hemihydrate
2(C8H20N),C46H30N10NiO4S42,0.5H2O
Acta Crystallographica Section E (2007) 63, 5 m1373-m1374
a=14.4474(15)Å b=19.514(2)Å c=21.771(2)Å
α=90.00° β=97.642(2)° γ=90.00°
Aqua[N,N'-bis(4-methyl-1,3-benzothiazol-2-yl)pyridine-2,6- dicarboxamidato(2-)]copper(II)
C23H17CuN5O3S2
Acta Crystallographica Section E (2007) 63, 5 m1259-m1260
a=8.7570(11)Å b=11.208(2)Å c=11.302(2)Å
α=89.910(3)° β=76.450(3)° γ=89.530(3)°
Methyl 3-(3,5-di-<i>tert</i>-butyl-4-hydroxyphenyl)propionate
C18H28O3
Acta Crystallographica Section C (2014) 70, 11 1050-1053
a=5.9191(14)Å b=18.164(4)Å c=16.605(4)Å
α=90.00° β=98.343(6)° γ=90.00°
C34H18CuN4O14
C34H18CuN4O14
ACS omega (2019) 4, 1 1995-2000
a=17.033(2)Å b=28.521(6)Å c=15.290(2)Å
α=90.00° β=90.00° γ=90.00°
C37H21Cl3CuN4O10
C37H21Cl3CuN4O10
ACS omega (2019) 4, 1 1995-2000
a=17.1736(6)Å b=28.5197(11)Å c=15.4911(5)Å
α=90.00° β=90.00° γ=90.00°
C8Co12Fe4Na19O232P4Si4W36
C8Co12Fe4Na19O232P4Si4W36
Journal of the American Chemical Society (2019) 141, 1 232-239
a=23.4377(4)Å b=25.9959(5)Å c=18.9014(4)Å
α=90° β=90° γ=90°
Co8Fe8Na13O233P4Si4W36
Co8Fe8Na13O233P4Si4W36
Journal of the American Chemical Society (2019) 141, 1 232-239
a=25.9719(5)Å b=23.5149(6)Å c=18.9224(3)Å
α=90° β=90° γ=90°
C34H20CuN4O11
C34H20CuN4O11
ACS omega (2019) 4, 1 1995-2000
a=17.354(2)Å b=28.747(5)Å c=15.0069(19)Å
α=90.00° β=90.00° γ=90.00°